Successful creation of tissue-engineered autologous auricular cartilage in an immunocompetent large animal model

Tissue Engineering - Part A

Volumn 20, Issue 1-2, 2014, Pages 303-312

  Bichara, David A ^a,b   Pomerantseva, Irina ^a,b   Zhao, Xing ^a,b   Zhou, Libin ^a,c   Kulig, Katherine M ^a   Tseng, Alan ^a   Kimura, Anya M ^a   Johnson, Matthew A ^a   Vacanti, Joseph P ^a,b   Randolph, Mark A ^a,b   Sundback, Cathryn A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Department of Stomatology 513rd Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; COLLAGEN; ELASTIN; GLYCOPROTEINS; MAMMALS; TISSUE;

CARTILAGE FORMATION; CHONDROCYTES; COLLAGEN SCAFFOLDS; DNA QUANTIFICATION; GLYCOSAMINOGLYCANS; IMPLANTATION TIME; TISSUE ENGINEERED CARTILAGE; TOLUIDINE BLUE;

CARTILAGE;

COLLAGEN TYPE 2; EOSIN; TISSUE SCAFFOLD;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; AUTOTRANSPLANTATION; CARTILAGE CELL; CELL ADHESION; CELL EXPANSION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA CONTENT; EAR CARTILAGE; EXPERIMENTAL SHEEP; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING; TISSUE EXPANSION;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; DNA; EAR CARTILAGE; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MODELS, ANIMAL; PROSTHESIS IMPLANTATION; SHEEP; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84891532731     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0150     Document Type: Article

References (47)

1. Walton, R.L., and Beahm, E.K. Auricular reconstruction for microtia: Part II. Surgical techniques. Plast Reconstr Surg 110, 234 quiz 50-1, 387, 2002.
2. Braun, T., Gratza, S., Becker, S., Schwentner, I., Stelter, K., Patscheider, M., et al. Auricular reconstruction with porous polyethylene frameworks: outcome and patient benefit in 65 children and adults. Plast Reconstr Surg 126, 1201, 2010.
3. Bauer, B.S. Reconstruction of microtia. Plast Reconstr Surg 124, 14e, 2009.
4. Xu, J.W., Johnson, T.S., Motarjem, P.M., Peretti, G.M., Randolph, M.A., and Yaremchuk, M.J. Tissue-engineered flexible ear-shaped cartilage. Plast Reconstr Surg 115, 1633, 2005.
5. Isogai, N., Morotomi, T., Hayakawa, S., Munakata, H., Tabata, Y., Ikada, Y., et al. Combined chondrocyte-copolymer implantation with slow release of basic fibroblast growth factor for tissue engineering an auricular cartilage construct. J Biomed Mater Res A 74, 408, 2005.
6. Haisch, A., Klaring, S., Groger, A., Gebert, C., and Sittinger, M. A tissue-engineering model for the manufacture of auricular- shaped cartilage implants. Eur Arch Otorhinolaryngol 259, 316, 2002.
7. Isogai, N., Asamura, S., Higashi, T., Ikada, Y., Morita, S., Hillyer, J., et al. Tissue engineering of an auricular cartilage model utilizing cultured chondrocyte-poly(L-lactide-epsilon- caprolactone) scaffolds. Tissue Eng 10, 673, 2004.
8. Isogai, N., Nakagawa, Y., Suzuki, K., Yamada, R., Asamura, S., Hayakawa, S., et al. Cytokine-rich autologous serum system for cartilaginous tissue engineering. Ann Plast Surg 60, 703, 2008.
9. Kusuhara, H., Isogai, N., Enjo, M., Otani, H., Ikada, Y., Jacquet, R., et al. Tissue engineering a model for the human ear: assessment of size, shape, morphology, and gene expression following seeding of different chondrocytes. Wound Repair Regen 17, 136, 2009.
10. Zhou, L., Pomerantseva, I., Bassett, E.K., Bowley, C.M., Zhao, X., Bichara, D.A., et al. Engineering ear constructs with a composite scaffold to maintain dimensions. Tissue Eng Part A 17, 1573, 2011.
11. Xue, J., Feng, B., Zheng, R., Lu, Y., Zhou, G., Liu, W., et al. Engineering ear-shaped cartilage using electrospun fibrous membranes of gelatin/polycaprolactone. Biomaterials 34, 2624, 2013.
12. Reiffel, A.J., Kafka, C., Hernandez, K.A., Popa, S., Perez, J.L., Zhou, S., et al. High-fidelity tissue engineering of patient-specific auricles for reconstruction of pediatric microtia and other auricular deformities. PLoS One 8, e56506, 2013.
13. Bichara, D.A., O'Sullivan, N.A., Pomerantseva, I., Zhao, X., Sundback, C.A., Vacanti, J.P., et al. The tissue-engineered auricle: past, present, and future. Tissue Eng Part B Rev 18, 51, 2012.
14. Yanaga, H., Imai, K., Fujimoto, T., and Yanaga, K. Generating ears from cultured autologous auricular chondrocytes by using two-stage implantation in treatment of microtia. Plast Reconstr Surg 124, 817, 2009.
15. Chang, S.C., Tobias, G., Roy, A.K., Vacanti, C.A., and Bonassar, L.J. Tissue engineering of autologous cartilage for craniofacial reconstruction by injection molding. Plast Reconstr Surg 112, 793, discussion 800-1, 2003.
16. Xia, W., Liu, W., Cui, L., Liu, Y., Zhong, W., Liu, D., et al. Tissue engineering of cartilage with the use of chitosangelatin complex scaffolds. J Biomed Mater Res B Appl Biomater 71, 373, 2004.
17. Cao, Y., Rodriguez, A., Vacanti, M., Ibarra, C., Arevalo, C., and Vacanti, C.A. Comparative study of the use of poly(- glycolic acid), calcium alginate and pluronics in the engineering of autologous porcine cartilage. J Biomater Sci Polym Ed 9, 475, 1998.
18. Kamil, S.H., Vacanti, M.P., Aminuddin, B.S., Jackson, M.J., Vacanti, C.A., and Eavey, R.D. Tissue engineering of a human sized and shaped auricle using a mold. Laryngoscope 114, 867, 2004.
19. Arevalo-Silva, C.A., Eavey, R.D., Cao, Y., Vacanti, M., Weng, Y., and Vacanti, C.A. Internal support of tissueengineered cartilage. Arch Otolaryngol Head Neck Surg 126, 1448, 2000.
20. Shieh, S.J., Terada, S., and Vacanti, J.P. Tissue engineering auricular reconstruction: in vitro and in vivo studies. Biomaterials 25, 1545, 2004.
21. Kanazawa, S., Fujihara, Y., Sakamoto, T., Asawa, Y., Komura, M., Nagata, S., et al. Tissue responses against tissueengineered cartilage consisting of chondrocytes encapsulated within non-absorbable hydrogel. J Tissue Eng Regen Med 7, 1, 2013.
22. Saim, A.B., Cao, Y., Weng, Y., Chang, C.N., Vacanti, M.A., Vacanti, C.A., et al. Engineering autogenous cartilage in the shape of a helix using an injectable hydrogel scaffold. Laryngoscope 110, 1694, 2000.
23. Monroy, A., Kojima, K., Ghanem, M.A., Paz, A.C., Kamil, S., Vacanti, C.A., et al. Tissue engineered cartilage "bioshell" protective layer for subcutaneous implants. Int J Pediatr Otorhinolaryngol 71, 547, 2007.
24. Christophel, J.J., Chang, J.S., and Park, S.S. Transplanted tissue-engineered cartilage. Arch Facial Plast Surg 8, 117, 2006.
25. Fussenegger, M., Meinhart, J., Hobling, W., Kullich, W., Funk, S., and Bernatzky, G. Stabilized autologous fibrinchondrocyte constructs for cartilage repair in vivo. Ann Plast Surg 51, 493, 2003.
26. Rotter, N., Ung, F., Roy, A.K., Vacanti, M., Eavey, R.D., Vacanti, C.A., et al. Role for interleukin 1alpha in the inhibition of chondrogenesis in autologous implants using polyglycolic acid-polylactic acid scaffolds. Tissue Eng 11, 192, 2005.
27. Fujihara, Y., Asawa, Y., Takato, T., and Hoshi, K. Tissue reactions to engineered cartilage based on poly-L-lactic acid scaffolds. Tissue Eng Part A 15, 1565, 2009.
28. Fujihara, Y., Takato, T., and Hoshi, K. Immunological response to tissue-engineered cartilage derived from auricular chondrocytes and a PLLA scaffold in transgenic mice. Biomaterials 31, 1227, 2010.
29. Haisch, A. Ear reconstruction through tissue engineering. Adv Otorhinolaryngol 68, 108, 2010.
30. Liu, W., and Cao, Y. Application of scaffold materials in tissue reconstruction in immunocompetent mammals: our experience and future requirements. Biomaterials 28, 5078, 2007.
31. Moretti, M., Wendt, D., Dickinson, S.C., Sims, T.J., Hollander, A.P., Kelly, D.J., et al. Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model. Tissue Eng 11, 1421, 2005.
32. Deponti, D., Di Giancamillo, A., Mangiavini, L., Pozzi, A., Fraschini, G., Sosio, C., et al. Fibrin-based model for cartilage regeneration: tissue maturation from in vitro to in vivo. Tissue Eng Part A 18, 1109, 2012.
33. Luo, X., Zhou, G., Liu, W., Zhang, W.J., Cen, L., Cui, L., et al. In vitro precultivation alleviates post-implantation inflammation and enhances development of tissue-engineered tubular cartilage. Biomed Mater 4, 025006, 2009.
34. Jin, C.Z., Cho, J.H., Choi, B.H., Wang, L.M., Kim, M.S., Park, S.R., et al. The maturity of tissue-engineered cartilage in vitro affects the repairability for osteochondral defect. Tissue Eng Part A 17, 3057, 2011.
35. Miot, S., Brehm, W., Dickinson, S., Sims, T., Wixmerten, A., Longinotti, C., et al. Influence of in vitro maturation of engineered cartilage on the outcome of osteochondral repair in a goat model. Eur Cell Mater 23, 222, 2012.
36. Schaefer, D., Martin, I., Jundt, G., Seidel, J., Heberer, M., Grodzinsky, A., et al. Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum 46, 2524, 2002.
37. Blunk, T., Sieminski, A.L., Gooch, K.J., Courter, D.L., Hollander, A.P., Nahir, A.M., et al. Differential effects of growth factors on tissue-engineered cartilage. Tissue Eng 8, 73, 2002.
38. Pei, M., Seidel, J., Vunjak-Novakovic, G., and Freed, L.E. Growth factors for sequential cellular de- and re-differentiation in tissue engineering. Biochem Biophys Res Commun 294, 149, 2002.
39. Morotomi, T., Wada, M., Uehara, M., Enjo, M., and Isogai, N. Effect of local environment, fibrin, and basic fibroblast growth factor incorporation on a canine autologous model of bioengineered cartilage tissue. Cells Tissues Organs 196, 398, 2012.
40. Schulze-Tanzil, G., Mobasheri, A., de Souza, P., John, T., and Shakibaei, M. Loss of chondrogenic potential in dedifferentiated chondrocytes correlates with deficient Shc-Erk interaction and apoptosis. Osteoarthritis Cartilage 12, 448, 2004.
41. Bobick, B.E., Chen, F.H., Le, A.M., and Tuan, R.S. Regulation of the chondrogenic phenotype in culture. Birth Defects Res C Embryo Today 87, 351, 2009.
42. Beekman, B., Verzijl, N., de Roos, J.A., and TeKoppele, J.M. Matrix degradation by chondrocytes cultured in alginate: IL- 1 beta induces proteoglycan degradation and proMMP synthesis but does not result in collagen degradation. Osteoarthritis Cartilage 6, 330, 1998.
43. Lima, E.G., Tan, A.R., Tai, T., Bian, L., Stoker, A.M., Ateshian, G.A., et al. Differences in interleukin-1 response between engineered and native cartilage. Tissue Eng Part A 14, 1721, 2008.
44. Scotti, C., Osmokrovic, A., Wolf, F., Miot, S., Peretti, G.M., Barbero, A., et al. Response of human engineered cartilage based on articular or nasal chondrocytes to interleukin-1beta and low oxygen. Tissue Eng Part A 18, 362, 2012.
45. Francioli, S., Cavallo, C., Grigolo, B., Martin, I., and Barbero, A. Engineered cartilage maturation regulates cytokine production and interleukin-1beta response. Clin Orthop Relat Res 469, 2773, 2011.
46. Lotz, A.S., Havla, J.B., Richter, E., Frolich, K., Staudenmaier, R., Hagen, R., et al. Cytotoxic and genotoxic effects of matrices for cartilage tissue engineering. Toxicol Lett 190, 128, 2009.
47. Sterodimas, A., and de Faria, J. Human auricular tissue engineering in an immunocompetent animal model. Aesthet Surg J 33, 283, 2013.